Free Trial
LON:PCA

Palace Capital H2 2025 Earnings Report

Palace Capital logo
GBX 170 +8.00 (+4.94%)
As of 11:52 AM Eastern

Palace Capital EPS Results

Actual EPS
GBX 11.30
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Palace Capital Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Palace Capital Announcement Details

Quarter
H2 2025
Time
Before Market Opens
Conference Call Date
Thursday, June 5, 2025
Conference Call Time
2:00AM ET

Earnings Documents

Palace Capital Earnings Headlines

PCA Stock Price Quote | Morningstar
Palace Capital PLC (PCA) - Investing.com UK
Peptide Company Lands Exclusive MMA Wellness Partnership
A publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform tied to Conor McGregor and Dana White - reaching millions of combat sports and biohacking followers worldwide. On April 15, RFK Jr. announced the FDA would remove 12 peptides from restricted Category 2 status. This company was already selling products tied to three of those peptides - and has developed a patent-pending transdermal patch addressing the 63.2% of adults with needle phobia. The peptide therapeutics market is projected to reach $294 billion by 2033.tc pixel
Palace Capital Regulatory News
See More Palace Capital Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Palace Capital? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Palace Capital and other key companies, straight to your email.

About Palace Capital

Property investment company that has a diversified portfolio of UK regional commercial real estate in carefully selected locations outside of London

View Palace Capital Profile